Sunday 11 October 2026
Export all MKSI data to Excel Powerpack
MKS Inc.
MKSI Technology Scientific & Technical Instruments
MKS Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 9.62% from fiscal 2024. In the quarter to June 2026, revenue grew 28.3%, EPS grew 181.5%, free cash flow grew 39.0% and total debt fell 10.5%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
264.50
4.12
+1.58%
Follow MKSI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
29.97 | 36.40 | 47.29 | 68.12 |
P/S ratio |
2.17 | 2.74 | 3.80 | 6.92 | |
P/FCF ratio |
15.69 | 21.51 | 38.24 | 65.65 | |
P/Operating CF |
42.28 | 75.74 | 292.25 | 123.74 | |
P/B ratio |
3.20 | 3.96 | 5.51 | 10.06 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.12 | 3.63 | 4.66 | 7.68 | |
EV/EBITDA |
13.38 | 15.90 | 20.31 | 31.93 | |
EV/Operating CF |
17.58 | 22.14 | 34.05 | 52.60 | |
EV/FCF |
22.48 | 28.56 | 46.84 | 72.93 | |
Quick Ratio |
1.48 | 1.43 | 0.59 | 0.59 | |
Current Ratio |
2.86 | 2.71 | 1.11 | 1.14 | |
Net Debt/EBITDA |
15.61 | 14.94 | 14.62 | 9.77 | |
Debt/Assets |
49.04% | 47.76% | 46.38% | 44.10% | |
Debt/Equity |
1.66 | 1.55 | 1.44 | 1.32 | |
Asset Turnover |
0.43 | 0.45 | 0.47 | 0.49 | |
Operating CF/Net income |
2.66 | 1.33 | 0.63 | 1.39 | |
Capex/Depreciation |
(0.55) | (0.51) | (0.28) | (0.60) | |
Interest Coverage |
2.60 | 2.82 | 3.31 | 6.61 | |
Research and Development Expense of Revenue |
7.69% | 7.45% | 7.51% | 6.09% | |
Selling, General and Administrative Expense of Revenue |
18.22% | 17.79% | 17.63% | 16.03% | |
Intangible Assets out of Total Assets |
0.54 | 0.54 | 0.53 | 0.51 | |
Share Based Compensation of Revenue |
1.21% | 0.87% | 1.76% | 1.20% | |
Graham Net Nets |
(0.44) | (0.33) | (0.22) | (0.11) | |
Graham Number |
59.92 | 63.17 | 67.53 | 80.59 | |
Earnings Yield |
3.34% | 2.75% | 2.11% | 1.47% | |
Free Cash Flow Yield |
6.37% | 4.65% | 2.61% | 1.52% | |
Revenue per Share |
14.68 | 15.36 | 15.99 | 18.46 | |
Operating CF per Share |
2.93 | 2.11 | 0.79 | 3.59 | |
Capex per Share |
(0.76) | (0.70) | (0.37) | (0.80) | |
Free Cash Flow per Share |
2.17 | 1.41 | 0.42 | 2.80 | |
Cash per Share |
10.36 | 10.03 | 8.44 | 9.04 | |
Shareholders Equity per Share |
38.63 | 40.40 | 41.71 | 44.20 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
38.63 | 40.40 | 41.71 | 44.20 | |
Free Cash Flow |
146.00 | 95.00 | 28.00 | 189.00 | |
Working Capital |
1,650.00 | 1,583.00 | 254.00 | 350.00 | |
Capital Expenditures |
(51.00) | (47.00) | (25.00) | (54.00) | |
Net Current Asset Value |
(3,641.00) | (3,567.00) | (3,372.00) | (3,179.00) | |
EV/EBIT |
22.91 | 27.05 | 33.51 | 48.97 | |
Capex to Sales |
0.05 | 0.05 | 0.02 | 0.04 | |
Price to Operating Income |
15.99 | 20.37 | 27.37 | 44.09 | |
| Other line items | |||||
Average Receivables |
610.00 | 633.00 | 707.00 | 739.50 | |
Average Payables |
344.00 | 374.00 | 385.50 | 444.50 | |
Average Inventory |
937.00 | 907.00 | 921.50 | 975.50 | |
Average Assets |
8,900.00 | 8,693.00 | 8,642.00 | 8,883.50 | |
Average Common Equity |
2,499.00 | 2,520.50 | 2,582.50 | 2,770.50 |
Columns are period end dates